Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimized pegylated interferon treatment for inactive HBsAg carriers
ChiCTR1800017020Phase 4Recruiting
- Sponsor
- Beijing YouAn Hospital
- Start
- Aug 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of pegylated interferon alpha in hepatitis B (HBV) (2 arms), sponsored by Beijing YouAn Hospital. Primary endpoint: HBsAg. Started Aug 2018; status: recruiting.
02
Drugs
pegylated interferon alpha
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on ChiCTR1800017020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017020.